Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro
Background: Excessive subcutaneous adiposity in obesity is associated to positive white adipocyte tissue (WAT) differentiation (adipogenesis) and WAT expandability. Here, we hypothesized that supplementation with the insulin inhibitor and mitochondrial uncoupler, Tyrphostin (T-AG17), in vitro and in...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2018
|
Subjects: | |
Online Access: | http://eprints.uanl.mx/16231/1/137.pdf |
_version_ | 1824414542870872064 |
---|---|
author | Camacho Morales, Alberto Segoviano Ramírez, Juan Carlos Sánchez García, Adriana Herrera de la Rosa, José de Jesús García Juárez, Jaime Hernandez Puente, Carlos Alberto Calvo Anguiano, Geovana Maltos Uro, Sergio Rodolfo Olguin, Alejandra Gojon Romanillos, Gabriel Gojon Zorrilla, Gabriel Ortiz López, Rocío |
author_facet | Camacho Morales, Alberto Segoviano Ramírez, Juan Carlos Sánchez García, Adriana Herrera de la Rosa, José de Jesús García Juárez, Jaime Hernandez Puente, Carlos Alberto Calvo Anguiano, Geovana Maltos Uro, Sergio Rodolfo Olguin, Alejandra Gojon Romanillos, Gabriel Gojon Zorrilla, Gabriel Ortiz López, Rocío |
author_sort | Camacho Morales, Alberto |
collection | Repositorio Institucional |
description | Background: Excessive subcutaneous adiposity in obesity is associated to positive white adipocyte tissue (WAT) differentiation (adipogenesis) and WAT expandability. Here, we hypothesized that supplementation with the insulin inhibitor and mitochondrial uncoupler, Tyrphostin (T-AG17), in vitro and in vivo inhibits adipogenesis and adipocyte hypertrophy.
Methods: We used a 3T3-L1 proadipocyte cell line to identify the potential effect of T-AG17 on adipocyte differentiation and fat accumulation in vitro. We evaluated the safety of T-AG17 and its effects on physiological and molecular metabolic parameters including hormonal profile, glucose levels, adipogenesis and adipocyte hypertrophy in a diet-induced obesity model using C57BL/6 mice.
Results: We found that T-AG17 is effective in preventing adipogenesis and lipid synthesis in the 3T3-L1 cell line, as evidenced by a significant decrease in oil red staining (p <0.05). In obese C57BL/6 mice, oral administration of T-AG17 (0.175 mg/kg for 2 weeks) lead to decreased fat accumulation and WAT hypertrophy. Further, T-AG17 induced adipocyte apoptosis by activating caspase-3. In the hepatocytes of obese mice, T-AG17 promoted an increase in the size of lipid inclusions, which was accompanied by glycogen accumulation. T-AG17 did not alter serum biochemistry, including glucose, insulin, leptin, free fatty acids, creatinine, and aspartate aminotransferase.
Conclusion: T-AG17 promotes adipocyte apoptosis in vivo and is an effective modulator of adipocyte differentiation and WAT hypertrophy in vitro and in vivo. Therefore, T-AG17 may be useful as a pharmacological obesity treatment. |
format | Article |
id | eprints-16231 |
institution | UANL |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | eprints |
spelling | eprints-162312024-02-28T18:32:45Z http://eprints.uanl.mx/16231/ Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro Camacho Morales, Alberto Segoviano Ramírez, Juan Carlos Sánchez García, Adriana Herrera de la Rosa, José de Jesús García Juárez, Jaime Hernandez Puente, Carlos Alberto Calvo Anguiano, Geovana Maltos Uro, Sergio Rodolfo Olguin, Alejandra Gojon Romanillos, Gabriel Gojon Zorrilla, Gabriel Ortiz López, Rocío QP Fisiología Background: Excessive subcutaneous adiposity in obesity is associated to positive white adipocyte tissue (WAT) differentiation (adipogenesis) and WAT expandability. Here, we hypothesized that supplementation with the insulin inhibitor and mitochondrial uncoupler, Tyrphostin (T-AG17), in vitro and in vivo inhibits adipogenesis and adipocyte hypertrophy. Methods: We used a 3T3-L1 proadipocyte cell line to identify the potential effect of T-AG17 on adipocyte differentiation and fat accumulation in vitro. We evaluated the safety of T-AG17 and its effects on physiological and molecular metabolic parameters including hormonal profile, glucose levels, adipogenesis and adipocyte hypertrophy in a diet-induced obesity model using C57BL/6 mice. Results: We found that T-AG17 is effective in preventing adipogenesis and lipid synthesis in the 3T3-L1 cell line, as evidenced by a significant decrease in oil red staining (p <0.05). In obese C57BL/6 mice, oral administration of T-AG17 (0.175 mg/kg for 2 weeks) lead to decreased fat accumulation and WAT hypertrophy. Further, T-AG17 induced adipocyte apoptosis by activating caspase-3. In the hepatocytes of obese mice, T-AG17 promoted an increase in the size of lipid inclusions, which was accompanied by glycogen accumulation. T-AG17 did not alter serum biochemistry, including glucose, insulin, leptin, free fatty acids, creatinine, and aspartate aminotransferase. Conclusion: T-AG17 promotes adipocyte apoptosis in vivo and is an effective modulator of adipocyte differentiation and WAT hypertrophy in vitro and in vivo. Therefore, T-AG17 may be useful as a pharmacological obesity treatment. BioMed Central 2018 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/16231/1/137.pdf http://eprints.uanl.mx/16231/1.haspreviewThumbnailVersion/137.pdf Camacho Morales, Alberto y Segoviano Ramírez, Juan Carlos y Sánchez García, Adriana y Herrera de la Rosa, José de Jesús y García Juárez, Jaime y Hernandez Puente, Carlos Alberto y Calvo Anguiano, Geovana y Maltos Uro, Sergio Rodolfo y Olguin, Alejandra y Gojon Romanillos, Gabriel y Gojon Zorrilla, Gabriel y Ortiz López, Rocío (2018) Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro. Lipids in Health and Disease, 17 (1). pp. 1-11. ISSN 1476-511X http://doi.org/10.1186/s12944-018-0784-7 doi:10.1186/s12944-018-0784-7 |
spellingShingle | QP Fisiología Camacho Morales, Alberto Segoviano Ramírez, Juan Carlos Sánchez García, Adriana Herrera de la Rosa, José de Jesús García Juárez, Jaime Hernandez Puente, Carlos Alberto Calvo Anguiano, Geovana Maltos Uro, Sergio Rodolfo Olguin, Alejandra Gojon Romanillos, Gabriel Gojon Zorrilla, Gabriel Ortiz López, Rocío Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
title | Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
title_full | Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
title_fullStr | Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
title_full_unstemmed | Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
title_short | Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro |
title_sort | tyrphostin ag17 inhibits adipocyte differentiation in vivo and in vitro |
topic | QP Fisiología |
url | http://eprints.uanl.mx/16231/1/137.pdf |
work_keys_str_mv | AT camachomoralesalberto tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT segovianoramirezjuancarlos tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT sanchezgarciaadriana tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT herreradelarosajosedejesus tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT garciajuarezjaime tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT hernandezpuentecarlosalberto tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT calvoanguianogeovana tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT maltosurosergiorodolfo tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT olguinalejandra tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT gojonromanillosgabriel tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT gojonzorrillagabriel tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro AT ortizlopezrocio tyrphostinag17inhibitsadipocytedifferentiationinvivoandinvitro |